These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3932721)

  • 1. [Oral administration of factor VIII or IX concentrate preparation].
    Sakuragawa N
    Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemophilia and haemorrhagic disorders.
    Stevens R
    Practitioner; 1993 Apr; 237(1525):350-4. PubMed ID: 8351278
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Emergency therapy and ambulatory care in hemophilia].
    Remde W
    Z Gesamte Inn Med; 1979 Jun; 34(12):154-6. PubMed ID: 315673
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary disorders of blood coagulation.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():51-64. PubMed ID: 785116
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of patients with bleeding disorders.
    Wyld PJ; Dawson KP
    N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophilia prophylaxis.
    JAMA; 1970 Jun; 212(13):2256-7. PubMed ID: 5310463
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of human viral disease transmission through plasma products.
    Heldebrant CM; Friedman AE; Fedor EJ
    Dev Biol Stand; 1987; 67():319-22. PubMed ID: 2440744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paradoxical bleeding as a complication of the treatment of hemophilia with factor VIII and factor IX preparations].
    Sutor AH
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):595-9. PubMed ID: 1714865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia care within the United Kingdom.
    Ludlam CA
    Haemophilia; 1998 Jul; 4(4):427-8. PubMed ID: 9873769
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 12. [Teeth extractions in 35 patients with hemophilia].
    Zhou SM; Gi LX; Yang TY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Sep; 29(5):291-3. PubMed ID: 7743865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hemophilias].
    Fischer M; Deutsch E
    Dtsch Med J; 1968 Jul; 19(14):499-505. PubMed ID: 5305713
    [No Abstract]   [Full Text] [Related]  

  • 14. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 15. Total hip replacement for patients with hemophilia and hemorrhagic diathesis.
    D'Ambrosia RD; Niemann KM; O'Grady L; Scott CW
    Surg Gynecol Obstet; 1974 Sep; 139(3):381-4. PubMed ID: 4546965
    [No Abstract]   [Full Text] [Related]  

  • 16. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y; Boyeldieu D; Stieltjes N
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and pasteurised factor VIII and IX concentrates.
    Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
    Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G
    Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
    [No Abstract]   [Full Text] [Related]  

  • 19. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.